Drug Information

Drug General Information
Drug ID
D04RYY
Former ID
DNC003015
Drug Name
Maltose
Drug Type
Small molecular drug
Indication Discovery agent Phase 1/2 [523849]
Structure
Download
2D MOL

3D MOL
Formula
C12H22O11
Canonical SMILES
C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O
InChI
1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2
InChIKey
GUBGYTABKSRVRQ-UHFFFAOYSA-N
CAS Number
CAS 69-79-4
PubChem Compound ID
294
PubChem Substance ID
69188, 5309774, 8137798, 8150555, 10506762, 10525406, 10528889, 10531314, 24438670, 24896492, 25628510, 26758438, 56369346, 57320109, 75611597, 81041809, 92298619, 93619828, 99299403, 103141050, 104294418, 117392489, 123166382, 125352241, 125353973, 125538705, 125538708, 125538717, 126442223, 126677944, 128006270, 137128024, 140346486, 152036274, 163131145, 163688398, 164239796, 165753885, 176254632, 176254712, 176256903, 176270380, 176327673, 179225857, 184587974, 223678966, 226978293, 249935554, 252449941
Target and Pathway
Target(s) Maltase-glucoamylase, intestinal Target Info Inhibitor [551391]
Alpha-glucosidase Target Info Inhibitor [551391]
KEGG Pathway Galactose metabolism
Starch and sucrose metabolism
Metabolic pathways
Carbohydrate digestion and absorption
PathWhiz Pathway Starch and Sucrose Metabolism
WikiPathways Metabolism of carbohydrates
References
Ref 523849ClinicalTrials.gov (NCT01562626) Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors. U.S. National Institutes of Health.
Ref 551391DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-4. Nucleic Acids Res. 2011 January

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.